{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:20:25Z","timestamp":1790835625538,"version":"4.1.0"},"reference-count":116,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02356","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:34:24Z","timestamp":1539563664000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":104,"title":["Regulatory T Cells in Systemic Sclerosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Camelia","family":"Frantz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Auffray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Avouac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fimmu.2012.00178","article-title":"Multiple treg suppressive modules and their adaptability","volume":"3","author":"Wing","year":"2012","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6012053","DOI":"10.1155\/2018\/6012053","article-title":"Immunological mechanisms in allergic diseases and allergen tolerance: the role of Treg cells","volume":"2018","author":"Calzada","year":"2018","journal-title":"J Immunol Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00125-017-4377-1","article-title":"Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?","volume":"60","author":"Hull","year":"2017","journal-title":"Diabetologia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3389\/fimmu.2015.00610","article-title":"Disturbed T cell signaling and altered Th17 and regulatory t cell subsets in the pathogenesis of systemic lupus erythematosus","volume":"6","author":"Rother","year":"2015","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/imr.12169","article-title":"Regulatory T cells in autoimmune neuroinflammation","volume":"259","author":"Kleinewietfeld","year":"2014","journal-title":"Immunol Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/08916930802282651","article-title":"Quantification and molecular characterization of regulatory T cells in connective tissue diseases","volume":"42","author":"Banica","year":"2009","journal-title":"Autoimmunity"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1182\/blood.V98.9.2736","article-title":"Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells","volume":"98","author":"Ng","year":"2001","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1084\/jem.193.11.1285","article-title":"Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood","volume":"193","author":"Jonuleit","year":"2001","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/eji.200526189","article-title":"Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level","volume":"35","author":"Roncador","year":"2005","journal-title":"Eur J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ni1455","article-title":"Foxp3 in control of the regulatory T cell lineage","volume":"8","author":"Zheng","year":"2007","journal-title":"Nat Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.4049\/jimmunol.178.11.6901","article-title":"Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses","volume":"178","author":"Stephens","year":"2007","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1073\/pnas.0509484103","article-title":"Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development","volume":"103","author":"Gavin","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.humimm.2004.05.016","article-title":"Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans","volume":"66","author":"Morgan","year":"2005","journal-title":"Hum Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J Exp Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.4049\/jimmunol.168.5.2212","article-title":"Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha","volume":"168","author":"Franchimont","year":"2002","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/80868","article-title":"Interleukin-7 mediates the homeostasis of na\u00efve and memory CD8 T cells in vivo","volume":"1","author":"Schluns","year":"2000","journal-title":"Nat Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/jid.2009.313","article-title":"CD127(low\/\u2013) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood","volume":"130","author":"Klein","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ni759","article-title":"Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance","volume":"3","author":"Shimizu","year":"2002","journal-title":"Nat Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1084\/jem.20071341","article-title":"OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection","volume":"205","author":"Piconese","year":"2008","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2008-04-150524","article-title":"CD49d provides access to \u201cuntouched\u201d human Foxp3+ Treg free of contaminating effector cells","volume":"113","author":"Kleinewietfeld","year":"2009","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","article-title":"Natural regulatory T cells: mechanisms of suppression","volume":"13","author":"Miyara","year":"2007","journal-title":"Trends Mol Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","article-title":"Regulatory T-cells in autoimmune diseases: challenges, controversies and\u2013yet\u2013unanswered questions","volume":"14","author":"Grant","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jbspin.2014.10.010","article-title":"Systemic sclerosis: recent insights","volume":"82","author":"Elhai","year":"2015","journal-title":"Joint Bone Spine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatol Oxf."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5301\/jsrd.5000249","article-title":"Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities","volume":"2","author":"Varga","year":"2017","journal-title":"J Scleroderma Relat Disord."},{"key":"B43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/path.1711660307","article-title":"Sequential dermal microvascular and perivascular changes in the development of scleroderma","volume":"166","author":"Prescott","year":"1992","journal-title":"J Pathol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum"},{"key":"B45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2362.1988.tb01158.x","article-title":"Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization","volume":"18","author":"Scharffetter","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"B46","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/1523-1747.ep12560826","article-title":"Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization","volume":"90","author":"K\u00e4h\u00e4ri","year":"1988","journal-title":"J Invest Dermatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","article-title":"Oligoclonal T cell expansion in the skin of patients with systemic sclerosis","volume":"168","author":"Sakkas","year":"2002","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1365-2133.2009.09213.x","article-title":"Clonal T-cell populations are frequent in the skin and blood of patients with systemic sclerosis","volume":"161","author":"Kreuter","year":"2009","journal-title":"Br J Dermatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/ard.2009.111906","article-title":"Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls","volume":"69","author":"Arnett","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/rheumatology\/ker335","article-title":"Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis","volume":"51","author":"Beretta","year":"2012","journal-title":"Rheumatol Oxf Engl."},{"key":"B51","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2169\/internalmedicine.38.336","article-title":"Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis","volume":"38","author":"Kuwana","year":"1999","journal-title":"Intern Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/sj.gene.6363734","article-title":"Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP","volume":"2","author":"Gilchrist","year":"2001","journal-title":"Genes Immun."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/ar3486","article-title":"Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease","author":"Truchetet","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/art.23406","article-title":"T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease","volume":"58","author":"Boin","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B55","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/archderm.1996.03890310088013","article-title":"Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis","volume":"132","author":"Salmon-Ehr","year":"1996","journal-title":"Arch Dermatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","article-title":"Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea","volume":"162","author":"Antiga","year":"2010","journal-title":"Br J Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e64531","DOI":"10.1371\/journal.pone.0064531","article-title":"Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction","volume":"8","author":"Liu","year":"2013","journal-title":"PloS ONE"},{"key":"B59","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/03009742.2010.528021","article-title":"Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis","volume":"40","author":"Papp","year":"2011","journal-title":"Scand J Rheumatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.clim.2011.01.013","article-title":"Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis","volume":"139","author":"Fenoglio","year":"2011","journal-title":"Clin Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/annrheumdis-2011-200709","article-title":"Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions","volume":"71","author":"Mathian","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"390563","DOI":"10.1155\/2013\/390563","article-title":"Assessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease","volume":"2013","author":"Cordiali-Fei","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/bjd.12913","article-title":"DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis","volume":"171","author":"Wang","year":"2014","journal-title":"Br J Dermatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/bmt.2013.202","article-title":"Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study","volume":"49","author":"Baraut","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B65","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3109\/14397595.2014.899736","article-title":"Decreased expression of Runx1 and lowered proportion of Foxp3+ CD25+ CD4+ regulatory T cells in systemic sclerosis","volume":"25","author":"Kataoka","year":"2015","journal-title":"Mod Rheumatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/ard.2009.116525","article-title":"Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma","volume":"70","author":"Klein","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5493\/wjem.v7.i3.84","article-title":"Treg\/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients","volume":"7","author":"Krasimirova","year":"2017","journal-title":"World J Exp Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e5981","DOI":"10.1371\/journal.pone.0005981","article-title":"Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression","volume":"4","author":"Radstake","year":"2009","journal-title":"PloS ONE"},{"key":"B69","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2009.12.009","article-title":"Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity","volume":"261","author":"Slobodin","year":"2010","journal-title":"Cell Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clim.2010.06.004","article-title":"Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes","volume":"137","author":"Giovannetti","year":"2010","journal-title":"Clin Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00296-011-2056-y","article-title":"Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study","volume":"32","author":"Rodr\u00edguez-Reyna","year":"2012","journal-title":"Rheumatol Int"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.3760\/cma.j.issn.0366-6999.20141395","article-title":"Correlation of Th17 cells and CD4+CD25+ regulatory T cells with clinical parameters in patients with systemic sclerosis","volume":"127","author":"Jiang","year":"2014","journal-title":"Chin Med J."},{"key":"B73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clim.2017.05.013","article-title":"Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis","volume":"184","author":"Ugor","year":"2017","journal-title":"Clin Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12016-016-8563-6","article-title":"Regulatory T cells in systemic sclerosis: a comprehensive review","volume":"52","author":"Slobodin","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","author":"Yang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1600-0404.2008.01090.x","article-title":"Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis","volume":"119","author":"Braitch","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"B77","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cellimm.2010.06.007","article-title":"Immunosuppressive therapy may affect the number of circulating regulatory cells in systemic sclerosis: pay attention to the patient selection criteria","volume":"264","author":"Antiga","year":"2010","journal-title":"Cell Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.rmed.2009.10.004","article-title":"T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension","volume":"104","author":"Austin","year":"2010","journal-title":"Respir Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000111548","article-title":"Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension","volume":"75","author":"Ulrich","year":"2008","journal-title":"Respir Int Rev Thorac Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.chest.2016.01.004","article-title":"Regulatory T cell dysfunction in idiopathic, heritable and connective tissue-associated pulmonary arterial hypertension","volume":"149","author":"Huertas","year":"2016","journal-title":"Chest"},{"key":"B81","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s12016-016-8590-3","article-title":"Epigenetic variability of CD4+CD25+ Tregs contributes to the pathogenesis of autoimmune diseases","volume":"52","author":"Shu","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.imbio.2017.10.004","article-title":"FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population","volume":"223","author":"D'Amico","year":"2018","journal-title":"Immunobiology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1136\/ard.2010.129999","article-title":"Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis","volume":"69","author":"Broen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00296-015-3269-2","article-title":"Semaphorin 3A: an immunoregulator in systemic sclerosis","volume":"35","author":"Rimar","year":"2015","journal-title":"Rheumatol Int."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"B87","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1002\/eji.200838950","article-title":"DC activated via dectin-1 convert Treg into IL-17 producers","volume":"38","author":"Osorio","year":"2008","journal-title":"Eur J Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"B89","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","article-title":"IL-17-producing human peripheral regulatory T cells retain suppressive function","volume":"113","author":"Beriou","year":"2009","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1172\/JCI37865","article-title":"Highly purified Th17 cells from BDC2","volume":"119","author":"Bending","year":"2009","journal-title":"J Clin Invest"},{"key":"B91","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nri2660","article-title":"Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective","volume":"9","author":"Weaver","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1073\/pnas.0900408106","article-title":"Identification of IL-17-producing FOXP3+ regulatory T cells in humans","volume":"106","author":"Voo","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B93","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1084\/jem.20072594","article-title":"Foxp3+ regulatory T cells maintain immune homeostasis in the skin","volume":"205","author":"Dudda","year":"2008","journal-title":"J Exp Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5301\/jsrd.5000220","article-title":"Updates on animal models of systemic sclerosis","volume":"1","author":"Soare","year":"2016","journal-title":"J Scleroderma Relat Disord"},{"key":"B96","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1002\/art.30539","article-title":"Immunization with DNA topoisomerase I and Freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling","volume":"63","author":"Yoshizaki","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.ajpath.2016.03.020","article-title":"CD4(+)CD25(hi)Foxp3(+) cells exacerbate bleomycin-induced pulmonary fibrosis","volume":"186","author":"Birjandi","year":"2016","journal-title":"Am J Pathol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12931-018-0783-2","article-title":"Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation","volume":"19","author":"Kamio","year":"2018","journal-title":"Respir Res"},{"key":"B99","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.imbio.2012.05.020","article-title":"Differential role of regulatory T cells in early and late stages of pulmonary fibrosis","volume":"218","author":"Boveda-Ruiz","year":"2013","journal-title":"Immunobiology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fimmu.2018.00303","article-title":"Therapeutic potential of gene-modified regulatory T cells: from bench to bedside","volume":"9","author":"Chae","year":"2018","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J Neuroinflamm"},{"key":"B102","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fimmu.2016.00334","article-title":"Clinical potential of regulatory T cell therapy in liver diseases: an overview and current perspectives","volume":"7","author":"Jeffery","year":"2016","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11926-016-0616-6","article-title":"Regulatory T cells in SLE: biology and use in treatment","volume":"18","author":"Giang","year":"2016","journal-title":"Curr Rheumatol Rep."},{"key":"B104","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2217\/imt-2016-0049","article-title":"Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside","volume":"8","author":"Kuhn","year":"2016","journal-title":"Immunotherapy"},{"key":"B105","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.coi.2015.09.002","article-title":"Targeting Treg signaling for the treatment of autoimmune diseases","volume":"37","author":"Spence","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11892-016-0807-6","article-title":"Restoring regulatory T cells in type 1 diabetes","volume":"16","author":"Spence","year":"2016","journal-title":"Curr Diab Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"179ra43","DOI":"10.1126\/scitranslmed.3005265","article-title":"Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease","volume":"5","author":"Matsuoka","year":"2013","journal-title":"Sci Transl Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1001\/jamadermatol.2014.504","article-title":"Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata","volume":"150","author":"Castela","year":"2014","journal-title":"JAMA Dermatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N Engl J Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fimmu.2018.00656","article-title":"Prophylactic and therapeutic effects of interleukin-2 (IL-2)\/Anti-IL-2 complexes in systemic lupus erythematosus-like chronic graft-versus-host disease","volume":"9","author":"Heiler","year":"2018","journal-title":"Front Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus","volume":"75","author":"von","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/ard.2010.137935","article-title":"The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study","volume":"70","author":"Becker","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van","year":"2014","journal-title":"JAMA"},{"key":"B114","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/rheumatology\/keq414","article-title":"Analysis of immune reconstitution after autologous CD34+ stem\/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells","volume":"50","author":"Tsukamoto","year":"2011","journal-title":"Rheumatol Oxf Engl"},{"key":"B116","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1182\/blood-2015-06-649145","article-title":"Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells","volume":"127","author":"Delemarre","year":"2016","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02356\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T19:57:30Z","timestamp":1693943850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02356\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":116,"alternative-id":["10.3389\/fimmu.2018.02356"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02356","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"article-number":"2356"}}